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O B J E C T I V E S This study sought to assess patterns and functional consequences of mitral
apparatus infarction after acute myocardial infarction (AMI).
B A C KG ROUND The mitral apparatus contains 2 myocardial components: papillary muscles and the
adjacent left ventricular (LV) wall. Delayed-enhancement cardiac magnetic resonance (DE-CMR) enables in vivo
study of inter-relationships and potential contributions of LV wall and papillary muscle infarction (PMI) to mitral
regurgitation (MR).
METHOD S Multimodality imaging was performed: CMR was used to assess mitral geometry and
infarct pattern, including 3D DE-CMR for PMI. Echocardiography was used to measure MR. Imaging
occurred 27  8 days after AMI (CMR, echocardiography within 1 day).
R E S U L T S A total of 153 patients with ﬁrst AMI were studied; PMI was present in 30% (n  46 [72%
posteromedial, 39% anterolateral]). When stratiﬁed by angiographic culprit vessel, PMI occurred in 65% of
patients with left circumﬂex, 48% with right coronary, and only 14% of patients with left anterior descending
infarctions (p0.001). Patients with PMI had more advanced remodeling as measured by LV size and mitral
annular diameter (p0.05). Increased extent of PMI was accompanied by a stepwise increase in mean infarct
transmurality within regional LV segments underlying each papillary muscle (p0.001). Prevalence of lateral
wall infarction was 3-fold higher among patients with PMI compared to patients without PMI (65% vs. 22%,
p0.001). Infarct distribution also impacted MR, with greater MR among patients with lateral wall infarction
(p  0.002). Conversely, MR severity did not differ on the basis of presence (p  0.19) or extent (p  0.12)
of PMI, or by angiographic culprit vessel. In multivariable analysis, lateral wall infarct size (odds ratio 1.20/%
LV myocardium [95% conﬁdence interval: 1.05 to 1.39], p  0.01) was independently associated with
substantial (moderate or greater) MR even after controlling for mitral annular (odds ratio 1.22/mm [1.04 to
1.43], p  0.01), and LV end-diastolic diameter (odds ratio 1.11/mm [0.99 to 1.23], p  0.056).
CONC L U S I O N S Papillary muscle infarction is common after AMI, affecting nearly one-third of
patients. Extent of PMI parallels adjacent LV wall injury, with lateral infarction—rather than PMI—
associated with increased severity of post-AMI MR. (J Am Coll Cardiol Img 2013;6:220–34) © 2013 by
the American College of Cardiology Foundation
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221itral regurgitation (MR) is a serious
consequence of acute myocardial in-
farction (AMI) that confers risk for
adverse outcomes, including heart fail-
re and death (1–3). Despite advances in coronary
eperfusion, MR remains common after AMI, oc-
urring in as many as 50% of patients (1,4). More-
ver, MR can beget MR, as regurgitation itself
ontributes to chamber dilation, hypertrophy, and
ystolic dysfunction (5–7). This cascade can further
istort both chamber and valve geometry, resulting
See page 235
in progressive MR. While mitral repair/replacement can
effectively treat severe MR and medical therapies
can prevent adverse remodeling, clinical outcomes
can be compromised if therapy is delayed (8–11).
Consistent with these clinical observations, animal
studies have demonstrated that early treatment of
even moderate MR can reduce left ventricular (LV)
volumes, attenuate adverse remodeling, and prevent
contractile dysfunction (6). Thus, identification of
indexes that predict development and progression
of post-AMI MR is important for implementation
of effective therapeutic interventions.
The mitral valve apparatus includes 2 myocardial
components: papillary muscles and the adjacent LV
wall (12). Both are believed to contribute to mitral
valve integrity through direct contractile effects to
maintain valve closure as well as secondary effects
on valve geometry (12,13). The link between pap-
illary muscle infarction (PMI) and severe MR is
well established in the context of papillary rupture
(14–16). It is also possible that lesser degrees of
papillary necrosis can produce lesser MR that in-
creases with time. However, PMI can occur with-
out rupture, a phenomenon originally reported in
experimental as well as autopsy studies (17–19), and
was recently shown in vivo using delayed-enhancement
(DE) cardiac magnetic resonance (CMR), which enables
high-resolution imaging of both PMI and LV wall
infarcts in a manner that closely agrees with pathology-
evidenced myocyte necrosis (20–22). Both PMI and LV
infarct distribution have been studied as isolated predic-
tors of MR. However, results have varied (5,23–26),
possibly because their inter-relationship and potential
independent contributions to MR have not been exam-
ined.
This study examined patterns and consequences
of mitral apparatus infarction after AMI. To this
end, CMR was performed to assess cardiac func-
tion, geometry, and infarct pattern, including high- uresolution 3-dimensional (3D) DE-CMR for PMI.
Transthoracic echocardiography (echo) was per-
formed for dedicated assessment of MR. The
aims were to determine 1) clinical and imaging
predictors of post-AMI PMI; and 2) relative
impact of PMI and adjacent LV wall infarction
on early post-AMI MR.
M E T H O D S
Population. The population consisted of consecu-
ive patients with first ST-segment elevation MI
nrolled in a prospective registry of post-AMI
emodeling (clinical trial #NCT00539045) between
eptember 2006 and August 2011 at Weill Cornell
edical College. Patients with intrinsic mitral
ysfunction (prolapse, rheumatic, prior sur-
ery) were excluded. Imaging was performed
ithin a pre-specified time limit of 6 weeks
fter AMI. All patients underwent CMR and
cho within 1 day.
Comprehensive clinical data were collected,
ncluding cardiac risk factors, coronary artery
isease history, New York Heart Association
unctional class, and medication regimen. Cor-
nary angiograms were reviewed for infarct
ocation and coronary dominance. Cardiac en-
ymes (creatine phosphokinase, myocardial
and fraction) were collected for serologic es-
imation of infarct size. The study was con-
ucted in accordance with the Weill Cornell
nstitutional review board.
Image acquisition. CARDIAC MAGNETIC
RESONANCE. CMR was performed using
.5-T scanners (General Electric, Wauke-
ha, Wisconsin). Examinations consisted
f 2 components: 1) cine-CMR for func-
ion/morphology; and 2) DE-CMR for
nfarct quantification. Cine-CMR was
erformed using a steady-state free precession pulse
equence. Short-axis images were acquired contig-
ously from the level of the mitral valve annulus
hrough the apex. Long-axis images were acquired
n standard 2-, 3-, and 4-chamber orientations.
E-CMR was performed after intravenous gad-
linium infusion (0.2 mmol/kg). In all patients,
ailored PMI imaging was attempted using a 3D
E-CMR pulse sequence that provides high-
esolution imaging (matrix size 256  256; typical
n-plane resolution 1.4  1.4mm, slice thickness 5
m) acquired during free-breathing by a navigator
ating algorithm (27). When 3D DE-CMR was
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222held 2-dimensional (2D) DE-CMR. For both 2D
and 3D DE-CMR, inversion times were adjusted
to null viable myocardium and contiguous short-
axis images were acquired throughout the LV.
ECHOCARDIOGRAPHY. Transthoracic echo was
performed by experienced sonographers using com-
mercially available equipment (General Electric
Vivid-7; Philips ie33) with phased-array transduc-
ers. Images were acquired using a pre-specified
registry protocol, including dedicated MR assess-
ment in accordance with American Society of
Echocardiography consensus guidelines (28). Imag-
ing was performed in parasternal, subcostal, and
apical 2-, 3-, and 4- chamber orientations. Color
Doppler was used to assess presence and severity of
MR on the basis of jet area, depth, vena contracta,
and directionality. Pulsed-wave Doppler included
assessment of MR duration and pulmonary vein
flow profile. Two-dimensional imaging was used
for related parameters, including mitral valve and
annular morphology.
Image interpretation. CARDIAC MAGNETIC RESO-
ANCE. DE-CMR was used to detect PMI. In
accordance with established criteria (13), papillary
muscles were defined as discrete myocardial struc-
tures within the LV cavity that were typically
circular in cross-sectional shape and either antero-
Figure 1. Representative Examples of Complete and Partial PM
Typical examples of (A) complete papillary muscle infarction (PMI) a
netic resonance. Each example is composed of 2 short-axis images
often associated with transmural infarction of the adjacent left ven
infarction. Upper right shows bilateral, complete PMI with transmural inlateral or posteromedial in location. PMI was
deemed present if any papillary hyperenhancement
was evident on DE-CMR short-axis images. PMI
was further categorized by location and extent—
partial or complete—stratified using a threshold of
50% papillary myocardium (Fig. 1).
Global LV infarct size (% LV myocardium) was
quantified on DE-CMR using the full-width at
half-maximum method (22,29). Reproducibility of
infarct size quantification, as tested in a subgroup
comprising 15% of the study population (n  23),
yielded small intraobserver (  0.2  1.5% LV
myocardium [limits of agreement  2.7% to
3.1%]) and interobserver differences (  0.6 
1.3% LV myocardium [limits of agreement 
3.3% to 2.0%]). Left ventricular infarct trans-
murality was scored using a 17-segment model, 5
points per segment scoring system (0  no hyper-
enhancement; 1  1% to 25%; 2  26% to 50%;
3  51% to 75%; 4  76% to 100%) (30). Relative
nfarct burden within designated anterior, inferior,
nd lateral territories (Fig. 2) was calculated as the
roportion of segmental scores contained within
ach territory, multiplied by global LV infarct size.
The CMR scan was also analyzed for conven-
ional indexes of cardiac structure and function.
he LV ejection fraction and cavity volumes were
(B) partial PMI detected by delayed-enhancement cardiac mag-
in the affected papillary muscle. As shown, complete PMI was
lar wall, whereas partial PMI was associated with subendocardialI
nd
with
tricufarction of the inferior and lateral walls.
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223based on end-diastolic and end-systolic endocardial
contours of contiguous short-axis images, with
end-diastolic diameter measured in short axis at
mid-LV level. Regional LV contractile function
was graded using a 17-segment, 5-point scoring
system (0  normal contraction; 1  mild hypoki-
esia; 2  moderate hypokinesia; 3  severe
ypokinesia; 4  akinesia; 5  dyskinesia). Left
trial and mitral geometric indexes were measured
n accordance with established methodological con-
entions (26,31). Left atrial area was planimetered
n 4-chamber orientation, with volume calculated
ased on area and chamber length (8/3 · area2/
length) from the posterior left atrium to the mitral
annulus (31). Mitral indexes were measured in
3-chamber orientation (26). Mitral annular diame-
ter was measured in a linear plane extending from
the respective junctions of anterior and posterior
valve leaflets with the atrial wall. Coaptation depth
was defined as the distance between leaflet coap-
tation and the mitral annulus. Tenting area en-
compassed the area enclosed between the annulus
and the mitral valve leaflets. Atrial and mitral
annular indexes were measured during ventricular
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anterolateral/inferolateral segments; inferior  inferior/inferoseptal
in green in respective bullseye plots), so that total myocardium subend systole.ECHOCARDIOGRAPHY. Echocardiography was the
reference for MR, which was quantified on the basis
of regurgitant fraction (RF). The RF was calculated
on the basis of differential stroke volume (SV) as
calculated (VTI · r2) using Doppler and 2D echo
indexes acquired at the mitral and aortic valve
annuli (RF  [SVmitral  SVaorta ] / SVmitral ·
100%). Reproducibility of MR quantification based
on regurgitant fraction (32,33) as well as study
center expertise for MR assessment (34–36) have
been previously reported. Severity of MR was
graded using established cutoffs in accordance with
American Society of Echocardiography guidelines
(mild, RF 30%; moderate, 30% to 39%;
moderate-severe, 40% to 49%; and severe, 50%)
(28). Each respective modality (CMR, echo) was
interpreted by an experienced reader blinded to
clinical data and other imaging tests.
Statistical methods. Comparisons of continuous vari-
ables were made using Student t test (expressed as
mean SD) for 2 group comparisons, with adjunctive
use of Levene test to assess for approximate equality of
variance between groups. Analysis of variance was
used for multiple group comparisons. Categorical
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224when 5 outcomes were expected per cell, Fisher
xact test. Ordinal variables were compared using
ruskal-Wallis 1-way analysis or the Jonckheere-
empestra test, with the latter used to test between-
Conventional Imaging Characteristics in Relation to PMI
Overall (n  153) PM
57 12
82% (126)
factors
46% (70)
mia 46% (70)
25% (38)
34% (52)
26% (40)
disease
5% (7)
1% (1)
ss, I/II/III/IV 82% (126)/14% (22)/3% (4)/1% (1) 78% (36)/
tions
97% (148)
inhibitor 94% (144)
5% (7)
7% (10)
100% (153)
95% (145)
26% (39)
ary intervention 75% (114)
nance
tion/geometry
% 52.5 11.9
0.8 0.6
5.5 0.5
ted 0.03 0.003 0
me, ml 153.1 42.4 1
me index, ml/m2 77.6 19.0
e, ml 75.5 37.4
e index, ml/m2 38.3 18.4
g 131.1 32.3 1
ndex, g/m2 66.4 14.2
r, cm 3.6 0.5
2 22.1 4.9
, ml 79.2 27.6
index, ml/m2 40.4 14.0
etry
, cm 2.8 0.4
, cm 0.6 0.2
0.9 0.4
% (n). Boldface indicates p values 0.05.
bypass graft surgery; EDD  end-diastolic diameter; HMG CoA  3-hydroxy-3-
ry muscle infarction.roup differences in graded MR severity. Logistic vegression was used to evaluate multivariable associa-
ions between imaging parameters and MR. Two-
ided p 0.05 was considered indicative of statistical
ignificance. Calculations were performed using SPSS
(n  46) PMI (n  107) p Value
 13 56 12 0.06
% (41) 79% (85) 0.15
% (23) 44% (47) 0.49
% (18) 49% (52) 0.28
% (12) 24% (26) 0.81
% (14) 36% (38) 0.54
% (13) 25% (27) 0.70
% (4) 3% (3) 0.20
% (1) 0% (0) 0.30
(7)/4% (2)/2% (1) 84% (90)/14% (15)/2% (2)/0% (0) 0.34
% (45) 96% (103) 1.00
% (44) 94% (100) 0.73
% (2) 5% (5) 1.00
% (4) 6% (6) 0.49
% (46) 95% (107) —
% (42) 96% (103) 0.24
% (12) 25% (27) 0.91
% (34) 75% (80) 0.91
 11.8 52.6 12.0 0.89
 0.6 0.8 0.6 0.45
 0.5 5.5 0.5 0.02
 0.003 0.032 0.003 0.04
 39.2 148.7 43.2 0.049
 17.6 76.0 19.4 0.11
 37.2 73.2 37.4 0.25
 18.3 37.4 18.5 0.38
 33.5 128.8 31.6 0.17
 14.7 65.8 14.0 0.42
 0.6 3.6 0.5 0.91
 5.4 22.0 4.7 0.87
 31.2 79.0 26.0 0.90
 15.0 40.7 13.6 0.67
 0.4 2.8 0.4 0.046
 0.2 0.6 0.2 0.82
 0.4 0.9 0.4 0.64
ylglutaryl-coenzyme A; MI  myocardial infarction; NYHA  New York HeartTable 1. Clinical and
I
Clinical
Age, yrs 60
Male 89
Atherosclerosis risk
Hypertension 50
Hypercholesterole 39
Diabetes mellitus 26
Tobacco use 30
Family history 28
Prior coronary artery
PCI 9
CABG 2
NYHA functional cla 15%
Cardiovascular medica
Beta-blocker 98
HMG CoA-reductase 96
Loop diuretic 4
Nitroglycerin 9
Aspirin 100
Thienopyridines 91
MI treatment strategy
Thrombolysis 26
Percutaneous coron 74
Cardiac magnetic reso
Left ventricular func
Ejection fraction, 52.3
Wall motion score 0.9
EDD, cm 5.7
EDD, height adjus .033
End-diastolic volu 63.4
End-diastolic volu 81.4
End-systolic volum 80.8
End-systolic volum 40.3
Myocardial mass, 36.7
Myocardial mass i 67.8
Left atrial geometry
Left atrial diamete 3.6
Left atrial area, cm 22.2
Left atrial volume 79.6
Left atrial volume 39.7
Mitral annular geom
Annulus diameter 2.9
Coaptation height 0.6
Tenting area, cm2 0.9
Values are mean  SD or
CABG  coronary artery methersion 19.0 (SPSS, Chicago, Illinois).
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225R E S U L T S
The population consisted of 153 patients with
AMI. CMR was performed 27  8 days after AMI
(90% 14 days). Echocardiography was performed
within 1 day of CMR in all patients (95% within 4 h).
Papillary muscle infarction was present in 30%
(n 46) of patients, among whom 72% had postero-
medial involvement and 39% had anterolateral papil-
lary involvement. Concomitant involvement of both
papillary muscles was present in 11% (5 of 46) of
affected patients. Figure 1 provides representative
examples of PMI identified by DE-CMR.
Table 1 details clinical and conventional imaging
characteristics of the study population, with strati-
fication on the basis of presence or absence of PMI.
Patients with PMI were clinically similar to patients
without PMI. Regarding imaging, results demon-
strate that PMI was associated with more advanced
remodeling based on LV chamber size and mitral
annular diameter (p  0.05).
Infarct parameters. Among the total of 46 patients
ith PMI, nearly half (48%) occurred in the context
f RCA culprit-vessel infarction, with the remain-
Table 2. Infarct Size and Distribution
PMI
Present
(n  46)
Absent
(n  107)
Infarct size
DE-CMR
% LV hyperenhancement 16.0 10.9 12.3 8.9
Cardiovascular enzymes
Creatine phosphokinase 2,590 2,344 2,164 1,83
Creatine phosphokinase-MB 243 207 199 188
Duration of symptoms
Chest pain interval, h 12.4 9.4 10.2 8.4
Infarct distribution
DE-CMR
Anterior wall 35% (16) 70% (75)
Lateral wall 65% (30) 22% (23)
Inferior wall 72% (33) 45% (48)
Anterior  inferior wall 15% (7) 20% (21)
Lateral  anterior wall 17% (8) 12% (13)
Lateral  inferior wall 50% (23) 11% (12)
Lateral  anterior  inferior wall 9% (4) 4% (4)
Angiography, infarct-related artery
Left anterior descending 28% (13) 72% (77)
Left circumﬂex 24% (11) 6% (6)
Right coronary 48% (22) 22% (24)
Anatomically dominant artery† 57% (26) 26% (28)
Values are mean  SD or % (n). Boldface indicates p values 0.05. *5 subjects ha
coronary artery.
CMR  cardiac magnetic resonance; DE  delayed enhancement; LV  left ventrier near evenly divided between left anterior de-
cending artery (LAD [28%]) and left circumflex
LCX [24%]) involvement. When stratified by
ulprit vessel, PMI occurred in 65% (11 of 17) of
atients with LCX, 48% (22 of 46) of patients with
CA, and only 14% (13 of 90) of patients with
AD infarcts (p 0.001).
Table 2 examines infarct-related parameters in rela-
ion to PMI. As shown, patients with PMI were more
ikely to have angiography-evidenced LCX culprit vessel
nvolvement (24% vs. 6%, p  0.001) or RCA culprit
essel involvement (48% vs. 22%, p  0.002) than
atients without PMI. Regarding infarct distribution on
E-CMR, prevalence of lateral wall infarction was
-fold higher among patients with, compared to patients
ithout, PMI (65% vs. 22%, p  0.001). Prevalence of
nferior wall infarction was 1.6-fold higher among pa-
ients with, compared to patients without, PMI (72% vs.
5%, p  0.003).
Regarding infarct size, Table 2 demonstrates that
verall % LV infarction by DE-CMR was larger
mong patients with PMI (p  0.03), with parallel
lbeit nonsignificant relationships between PMI
Posteromedial PMI Antero
p Value
Present
(n  33)*
Absent
(n  120) p Value
Present
(n  18)* (
0.03 15.4 10.8 12.9 9.2 0.19 20.2 13.3 1
0.25 2,351 1,782 2,271 2,057 0.85 2,962 3,118 2,2
0.30 256 206 199 189 0.21 191 200 2
0.17 12.4 9.6 10.4 8.5 0.29 13.7 9.6 1
<0.001 12% (4) 73% (87) <0.001 78% (14)
<0.001 73% (24) 24% (29) <0.001 61% (11)
0.003 91% (30) 43% (51) <0.001 44% (8)
0.52 12% (4) 20% (24) 0.30 28% (5)
0.39 6% (2) 16% (19) 0.25 44% (8)
<0.001 64% (21) 12% (14) <0.001 39% (7)
0.24 6% (2) 5% (6) 0.68 22% (4)
<0.001 0% (0) 75% (90) <0.001 72% (13)
0.001 33% (11) 5% (6) <0.001 22% (4)
0.002 67% (22) 20% (24) <0.001 6% (1)
<0.001 79% (26) 23% (28) <0.001 6% (1)
ncomitant posteromedial and anterolateral papillary muscle infarction (PMI). †Eithlateral PMI
Absent
n  135) p Value
2.5 8.7 0.03
6 01 1,794 0.36
16 195 0.70
0.5 8.6 0.15
57% (77) 0.09
31% (42) 0.01
54% (73) 0.44
17% (23) 0.33
10% (13) 0.001
21% (28) 0.13
3% (4) 0.007
57% (77) 0.22
10% (3) 0.12
33% (45) 0.02
39% (53) 0.005
d co er left circumﬂex or rightcular; MB  myocardial band.
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226and the enzymatic and clinical indexes of peak
creatine phosphokinase and chest pain duration
(both p  NS). However, the relation between
PMI and infarct size varied according to culprit
vessel involvement. Among patients with LAD
infarcts, LV infarct size (% myocardium) was sim-
lar between patients with and without PMI
18  11% vs. 15  9%, p  0.32). In contradistinc-
ion, Figure 3A illustrates that among patients with
ither RCA or LCX culprit involvement, PMI was
ccompanied by a more than 2-fold increase in LV
nfarct size (p  0.001 and p  0.056, respectively).
Although both RCA and LCX infarction in-
reased relative likelihood for PMI, the impact of
oronary dominance varied by culprit vessel. Figure
B first stratifies both RCA and LCX infarcts based
n PMI and then stratifies patients with PMI by
oronary dominance; among patients with RCA
nfarcts, PMI exclusively occurred (100%) in the
etting of right or codominant coronary anatomy,
hereas less than one-half (36%) of patients with
MI and LCX infarcts were left or codominant
p 0.0001). All RCA infarcts with PMI had postero-
edial involvement (n  22); 50% (11 of 22) had
nfarcts of the adjacent mid inferolateral wall.
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Figure 3. Infarct Size and Coronary Anatomy
(A) Infarct size (mean  SD) stratiﬁed by papillary muscle infarction
(right) left circumﬂex (LCX) culprit vessels. (B) Stratiﬁcation of RCA
nance pattern (lower row). LV  left ventricular.PMI extent and LV infarct transmurality. In more than
hree-fourths of cases (76%), PMI was partial,
s defined by 50% papillary hyperenhancement.
igure 4 compares PMI type by anatomic distribu-
ion, demonstrating that PMI type (partial vs.
omplete) did not differ between the anterolateral
nd posteromedial papillary muscles (p  0.50).
Figure 5 relates PMI type to both infarct trans-
urality and severity of contractile dysfunction in
he adjoining LV wall. As shown (Fig. 5A), in-
reased extent of PMI was accompanied by a
tepwise increase in mean infarct transmurality
ithin adjacent LV segments underlying each pap-
llary muscle (p  0.001). Similar results were
btained (Fig. 5B) when contractile dysfunction
segmental wall motion score) was used as a surro-
ate marker for injury (p  0.001).
Mitral regurgitation. Among the total study popula-
tion, echo-evidenced MR was mild or less in most
cases, with greater severity present in 14% (n  22)
f patients (moderate, n  7; moderate-severe, n 
2; severe, n  3). Table 3 reports univariate
nalyses examining CMR, biomarker, and x-ray
ngiography parameters in relation to presence or
bsence of substantial (moderate or greater) MR.
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227As shown, patients with moderate or greater MR
had worse LV dysfunction and more advanced LV,
left atrial, and mitral annular remodeling (p 
0.001) than patients with lesser or absent MR.
Regarding infarct pattern, Table 3 also demon-
strates that patients with moderate or greater MR
had greater prevalence of lateral wall infarction on
65%
33/51
PMI
Posteromedial
27%
9/33
Complete
73%
24/33
Partial
PMI
Distribution
PMI
Type
Figure 4. PMI Location and Type
Stratiﬁcation of papillary muscle infarction (PMI) by location (upper
among 46 patients (n  5 with bilateral PMI).
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Figure 5. PMI in Relation to Left Ventricular Injury
(A) Infarct transmurality and (B) contractile dysfunction stratiﬁed by
score (left) and maximum infarct score (right) in left ventricular (LV
inferior/inferolateral segments; anterolateral  mid anterior/anterol
of injury to adjacent LV segments, whether assessed by infarct transmuDE-CMR (p  0.001), with nonsignificant differ-
ences in infarct-related artery distribution poten-
tially attributable to variability in lateral wall coro-
nary vascular supply. Among patients with infarcts
that encompassed 1 LV region, only the combi-
nation of lateral plus anterior wall infarction was
more common among patients with increased MR,
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228consistent with the fact that patients with moderate
or greater MR had larger overall LV infarct size
(both p  0.01). In multivariable analysis, MR was
independently associated with presence of lateral
wall infarction (odds ratio [OR] 3.86 [95% confi-
dence interval (CI): 1.40 to 10.69], p 0.009) even
fter controlling for overall LV infarct size (OR
.07/% LV hyperenhancement [95% CI: 1.02 to
.12], p  0.01).
Figure 6 stratifies graded MR severity based
n PMI extent and LV infarct distribution on
Table 3. Cardiac Structure, Function, and Infarct Pattern in Rela
MR
Mitral annular geometry
Annulus diameter, cm 3.1
Coaptation height, cm 0.7
Tenting area, cm2 1.2
Left atrial geometry
Left atrial diameter, cm 4.2
Left atrial area, cm2 25.7
Left atrial volume, ml 98.8
Left atrial volume index, ml/m2 49.6
Left ventricular function/geometry
Ejection fraction, % 42.7
Wall motion score 1.4
End-diastolic diameter, cm 6.0
End-diastolic volume, ml 191.9
End-diastolic volume index, ml/m2 97.1
End-systolic volume, ml 113.8
End-systolic volume index, ml/m2 57.8
Myocardial mass, g 140.1
Myocardial mass index, g/m2 71.1
Left ventricular infarct pattern
Infarct size
% LV hyperenhancement 20.3
Creatine phosphokinase 2730
Creatine phosphokinase-MB 270
Infarct distribution (DE-CMR)
Anterior wall 64
Lateral wall 68
Inferior wall 59
Anterior  inferior wall 27
Lateral  anterior wall 41
Lateral  inferior wall 36
Lateral  anterior  inferior wall 14
PMI (DE-CMR) 41
Infarct-related artery (x-ray angiography)
Left anterior descending 55
Left circumﬂex 18
Right coronary 27
Values are mean  SD or % (n). Boldface indicates p values 0.05. *Stratiﬁed
MR  mitral regurgitation; other abbreviations as in Tables 1 and 2.E-CMR—corresponding data are detailed in tab- sular form below each bar graph. PMI, categorized by
extent of papillary muscle necrosis (p  0.12) or by
binary presence/absence (p  0.19), was not associ-
ated with increased MR severity. However, LV infarct
distribution did impact MR, as evidenced by increased
MR severity in association with presence of lateral wall
infarction (p 0.002). Of note, lateral wall infarct size
as more than 3-fold larger among patients (n  5)
ith concomitant anterolateral and posteromedial
MI compared to patients with absent or isolated PMI
p  0.001), paralleling a trend toward increased MR
to Mitral Regurgitation*
22) MR (n  131) p Value
.4 2.8 0.4 <0.001
.2 0.6 0.2 0.001
.5 0.8 0.3 <0.001
.6 3.6 0.5 <0.001
.7 21.6 4.5 <0.001
3.7 75.9 25.1 <0.001
6.5 38.9 13.0 0.001
2.2 54.2 11.0 <0.001
.8 0.7 0.5 <0.001
.6 5.5 0.7 <0.001
6.7 146.6 38.1 <0.001
5.7 74.3 15.4 <0.001
0.6 69.1 30.5 0.001
7.2 35.0 14.2 0.001
2.6 129.6 32.0 0.16
8.4 65.7 13.3 0.096
2.8 12.3 8.6 0.009
009 2215 1995 0.29
80 205 196 0.28
4) 59% (77) 0.67
5) 29% (38) <0.001
3) 52% (68) 0.53
) 17% (22) 0.24
) 9% (12) 0.001
) 21% (27) 0.10
) 4% (5) 0.09
) 28% (37) 0.23
2) 60% (78) 0.66
) 10% (13) 0.21
) 31% (40) 0.76
he basis of moderate or greater mitral regurgitation threshold.tion
(n 
 0
 0
 0
 0
 5
 3
 1
 1
 0
 0
 4
 2
 5
 2
 3
 1
 1
 2
 1
% (1
% (1
% (1
% (6
% (9
% (8
% (3
% (9
% (1
% (4
% (6
on teverity (p  0.09) in this group.
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229Logistic regression analysis was also used to test the
association of infarct distribution with MR after control-
ling for conventional structural indexes. In the univariate
analysis, presence of lateral wall infarction (OR 1.21/%
LV myocardium [95% CI: 1.08 to 1.37], p 0.001) was
M
itr
al
 R
eg
ur
gi
ta
tio
n
(p
re
v
a
la
nc
e)
No PMI
0%
50%
100%
Partial PMI
p = 0.12
M
itr
al
 R
eg
ur
gi
ta
tio
n
(p
re
v
a
la
nc
e)
Lateral Wall
0%
50%
100% p = 0.002
Absent Present
Inf
Abse
   
 Absent Mild 
  (RF < 30%
Absent 66% (66) 27% (27)
Present 45% (24) 26% (14)
Absent 63% (45) 25% (18)
Present 56% (45) 28% (23)
Absent 60% (37) 27% (17)
Present 58% (53) 26% (24)
Absent 62% (66) 26% (28)
Present 60% (21) 23% (8) 
Complete 27% (3) 46% (5) 
Mi
La
te
ra
l
In
fe
rio
r
A
nt
er
io
rL
V 
In
fa
rc
t
D
is
tr
ib
u
tio
n
Pa
pi
lla
ry
M
us
cl
e
In
fa
rc
tio
n
A
B
Figure 6. Mitral Regurgitation Severity
Graded severity of echocardiography-quantiﬁed mitral regurgitation
(bottom) left ventricular (LV) infarct distribution. Dark blue indicate
moderate; and yellow indicates mild. The corresponding table prov
RF  regurgitant fraction.significantly associated with substantial (moderate orgreater) MR, whereas PMI was not (OR 1.76 [95% CI:
0.69 to 4.46], p 0.24). Multivariate modeling was used
to test the independent association of lateral wall infarc-
tion with MR after controlling for conventional geomet-
ric indexes of mitral annular and LV size. As shown in
Mild
Moderate
Moderate - Severe
Severe
Mitral Regurgitation
omplete PMI
or Wall
 0.36
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230cardium [95% CI: 1.05 to 1.39], p  0.01) and mitral
annular diameter (OR 1.22/mm [95% CI: 1.05 to 1.45],
p  0.009) were independently associated with MR,
ith a similar trend for LV chamber diameter (OR
.11/mm [95% CI: 0.99 to 1.23], p 0.056). Substitu-
ion of lateral wall motion score (OR 1.25 [95% CI: 1.08
o 1.45], p  0.003) in the model (Table 4) also
emonstrated an independent association between lateral
all dysfunction and MR. In contradistinction, use of
ngiography data did not demonstrate an independent
ssociation for LCX (Table 4) culprit involvement. Sim-
lar results were obtained when RCA (OR 0.68 [95% CI:
.21 to 2.18], p  0.52) or LAD (OR 0.90 [95% CI:
.32 to 2.51], p 0.83) culprit involvement was substi-
uted in the model, consistent with overlap in coronary
ascular supply to the lateral wall.
D I S C U S S I O N
This study provides new insights regarding preva-
lence and physiologic consequences of infarction
within 2 components of the mitral valve apparatus:
Table 4. Structural Correlates of Mitral Regurgitation
Lateral W
Univariabl
Odds Ratio (95%
Lateral wall infarct size, % myocardium 1.21 (1.08–1.37)
Mitral annular diameter, mm 1.29 (1.13–1.48)
LV end-diastolic diameter, mm 1.20 (1.09–1.33)
PMI, complete or partial 1.76 (0.69–4.46)
Complete PMI 2.43 (0.59–9.97)
Partial PMI 1.57 (0.59–4.21)
Lateral Wa
Univariable R
Odds Ratio (95% CI)
Lateral wall contractile dysfunction
(wall motion score)
1.27 (1.13–1.43)
Mitral annular diameter, mm 1.29 (1.13–1.48)
LV end-diastolic diameter, mm 1.20 (1.09–1.33)
Infarct-Re
Univariable Reg
Odds Ratio (95% CI)
Left circumﬂex infarction 2.02 (0.59–6.87)
Mitral annular diameter, mm 1.29 (1.13–1.48)
LV end-diastolic diameter, mm 1.20 (1.09–1.33)
Boldface indicates p values 0.05.
CI  conﬁdence interval; other abbreviations as in Tables 1 and 2.papillary muscles and the adjacent LV wall. Keyfindings are as follows. 1) PMI is common in the
current era, affecting nearly one-third (30%) of
patients, with relative likelihood greater in the
context of LCX or dominant RCA infarcts. 2) PMI
typically occurs in the context of increased LV
infarct size, as evidenced by a greater than 2-fold
increase in infarct size among affected patients with
LCX or RCA infarcts. 3) Lateral wall infarction,
rather than presence or extent of PMI, is associated
with increased MR as measured early after AMI. In
multivariate analysis, post-AMI MR is associated
with lateral wall infarct size even after controlling
for both mitral annular and LV chamber dilation.
Our findings provide new insight into the rela-
tion between PMI and MR. Whereas prior studies
have reported similar PMI prevalence, results have
been discordant regarding PMI as a cause of MR.
For example, whereas Tanimoto et al. (25) found
no association between PMI and MR, Okayama et
al. (26) reported that the 2 were linked. Interest-
ingly, in the latter study, infarction of both papillary
nfarction
gression
Multivariable Regression
Model 2  29.37, p <0.001
p Value Odds Ratio (95% CI) p Value
0.001 1.20 (1.05–1.39) 0.01
<0.001 1.22 (1.05–1.45) 0.009
<0.001 1.11 (0.99–1.23) 0.056
0.24
0.22
0.37
ntractility
ession
Multivariable Regression
Model 2  32.23, p <0.001
p Value Odds Ratio (95% CI) p Value
<0.001 1.25 (1.08–1.45) 0.003
<0.001 1.24 (1.05–1.45) 0.009
<0.001 1.07 (0.95–1.21) 0.25
d Artery
sion
Multivariable Regression
Model 2  23.99, p <0.001
p Value Odds Ratio (95% CI) p Value
0.26 2.26 (0.59–8.72) 0.24
<0.001 1.20 (1.03–1.39) 0.02
<0.001 1.14 (1.03–1.27) 0.01all I
e Re
CI)
ll Co
egr
late
resmuscles was associated with increased MR whereas
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231single PMI was not. Our results suggest that LV
infarct pattern may explain these variable findings.
Among our population, only lateral wall infarction
was associated with increased MR, and the associ-
ation between lateral wall infarct size and MR
remained significant even after controlling for PMI
as well as conventional indexes of LV and mitral
geometry. PMI varied in both distribution and
extent, with greater magnitude of papillary necrosis
associated with increased infarct transmurality
within the adjacent LV wall, suggesting that prior
reported associations between bilateral PMI and
MR may be attributable to increased lateral wall
infarct size. Consistent with our results, an associ-
ation between lateral wall infarction and MR was
reported among patients with advanced LV dys-
function (LV ejection fraction 40%) (23), al-
though this prior study did not assess PMI, raising
questions as to underlying reasons for MR. To the
best of our knowledge, no prior study has examined
the inter-relationship of PMI and LV infarct dis-
tribution on post-AMI MR.
Our finding that PMI has a negligible impact on
MR is consistent with prior animal studies that
have examined papillary physiology. Using a canine
model in which coronary flow was reduced in a
graded fashion, Matsuzaki et al. (37) found that
papillary dysfunction alone was insufficient to cause
MR, which was instead associated with LV free
(lateral) wall hypokinesis and chamber dilation. The
importance of lateral wall dysfunction was also
demonstrated by Messas et al. (38), who performed
targeted LCX occlusion in a sheep model and found
that LV inferobasal ischemia produced MR,
whereas the addition of papillary ischemia paradox-
ically decreased MR by reducing leaflet tethering
and improving valve coaptation. Regarding mitral
geometry, animal studies by Kaul et al. (39) found
that MR was associated with incomplete mitral
valve closure rather than papillary ischemia. Clinical
studies have also supported this concept. Uemura et
al. (40), studying 40 patients with prior MI, re-
ported that papillary contractile dysfunction was
associated with induction of leaflet tethering and
MR attenuation, consistent with our multivariable
analysis demonstrating that extent of PMI was not
associated with increased MR. Taken together,
these prior data support our observation that lateral
wall injury and impaired valve coaptation, rather
than papillary dysfunction, are key determinants of
post-AMI MR.
It is important to recognize that animal studies
that have assessed LV injury patterns in vivo havetypically relied on LV or papillary contractile dys-
function as surrogates for infarction (37–39), with
questions remaining as to the direct impact of
myocyte necrosis on mitral valve function. Other
studies, which have assessed infarct size directly,
have demonstrated the importance of lateral wall
infarction using post-mortem analysis, raising un-
certainty as to the impact of intrinsic differences
between in vivo assessment of mitral geometry/MR
and ex-vivo infarct quantification (18,41). To ad-
dress these issues in a clinical setting, our study
employed multimodality imaging for in vivo assess-
ment of infarct size, mitral valve geometry, and
MR. The CMR and echo were acquired using a
tailored imaging protocol, with both tests per-
formed within a 1-day interval. Results, obtained in
a broad cohort of post-AMI patients, offer clinical
evidence that both impaired mitral valve geometry
(annular diameter) and lateral wall infarct size (%
hyperenhancement) are independently associated
with post-AMI MR, with a lesser, albeit signifi-
cant, magnitude of association for LV chamber
geometry as measured by end-diastolic diameter.
As DE-CMR provides a highly sensitive tool for
assessment of infarct morphology, an additional
study goal was to examine the relationship between
infarct burden within the papillary muscles and
adjacent LV wall. Prior DE-CMR studies, which
have also reported increased prevalence of PMI in
association with RCA and LCX culprit vessel
involvement, have categorized PMI and LV infarct
distribution in a binary fashion (25,26). Our study
examined graded extent of both papillary and LV
wall infarction. Results demonstrate that papillary
necrosis occurs in parallel with infarction of the
adjacent LV wall, as evidenced by increased LV
infarct size in association with greater extent of
PMI. Rather than the notion of papillary muscles as
end-organ structures particularly susceptible to jeop-
ardized arterial supply, our results support the concept
that papillary muscles and LV myocardium are simi-
larly vulnerable to impaired perfusion. Taken together
with our findings linking lateral wall infarct size to
MR, these data emphasize the importance of prompt
coronary reperfusion towards the common goals of
preserving LV viability, preventing adverse remodel-
ing, and minimizing MR after AMI.
In addition to CMR and echo, our study in-
cluded analysis of x-ray angiography for assessment
of mitral apparatus perfusion patterns. Results dem-
onstrated that right and left coronary dominance
bore a variable impact on PMI. Among patients
with RCA infarcts, all with PMI were right (or co-)
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232dominant whereas for patients with LCX infarcts,
less than half (36%) with PMI were left (or co-)
dominant (p  0.001). Additionally, we observed a
nearly 2-fold higher prevalence of posteromedial
(72%) compared to anterolateral (39%) PMI. This
difference may be explained by the fact that the
posteromedial papillary muscle is typically supplied
by a single coronary artery, whereas the anterolat-
eral papillary muscle is more frequently concomi-
tantly perfused by 2 coronary arteries (42). Regard-
ing MR, infarct-related culprit vessel was not
independently associated with valvular regurgita-
tion, consistent with the concept of variable arterial
supply to the lateral wall.
Study limitations. Several limitations should be rec-
ognized. First, despite inclusion of a broad cohort of
post-AMI patients, relatively few (14%) had sub-
stantial (moderate or greater) MR, consistent with
prior population based studies that have examined
MR after AMI (43,44). This limited our ability to
examine the independent contributions of all struc-
tural variables in relation to MR, and may have
resulted in some degree of overfitting in our mul-
tivariate models, which tested infarct distribution in
relation to the 2 established indexes (mitral annular,
left ventricular size) conventionally associated with
MR. Additionally, as very few affected patients had
severe MR, structural variables examined in this
study could not be correlated with graded severity of
valvular regurgitation. Although MR severity was
measured based on regurgitant fraction, it is
important to recognize that other well-validated
methods for MR assessment, including effective
regurgitant orifice area, were not tested. Finally,
as MR was assessed within 6 weeks (27  8 days)
of AMI, current findings may not apply to
longer-term severity of post-AMI MR. Indeed,
MR can dynamically change over time and belation 1997;96:827–33. Popovic AD. Earlytherapy. Additional research is necessary to ex-
amine the independent utility of mitral apparatus
infarct pattern—including PMI—for predicting
long-term MR severity.
C O N C L U S I O N S
In summary, this study demonstrates the inter-
relationship between papillary muscle and regional
LV infarction and identifies lateral wall infarction
(rather than PMI) as an independent marker for
increased MR as measured early after AMI. This is
the first in vivo study to directly link regional LV
infarct size and, by extension, infarct transmurality
to MR. These findings are relevant to the design of
therapies to treat MR, and to the tailoring of their
application to individual patients. Applied clini-
cally, findings suggest that LV plication therapies
(45) might be considered for CAD patients with
severe MR and transmural infarction, whereas cor-
onary reperfusion might be more beneficial as a
primary strategy for patients with preserved viability
in the lateral wall. DE-CMR also has the potential
to guide interventional treatments for MR, such as
targeted application of papillary repositioning
(46,47) based on infarct distribution. More broadly,
improved predictive models for MR are clinically
important to better identify and promptly treat at-risk
patients before development of adverse consequences
such as cardiac chamber remodeling, heart failure, and
arrhythmias. Further investigation is needed to test
long-term predictors of post-AMI MR, as well as the
utility of DE-CMR guided strategies to prevent or
treat MR and its complications.
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